Panda Capital

Danny Li, the founding partner, leads the investment committee with partner David Liang. The firm has a lean partnership structure — rare among Shanghai funds of its vintage to maintain a two-key decision model. Li's technical background means he typically leads diligence on AI and deep-tech deals, while Liang handles fintech and health-tech verticals.

The firm cultivates relationships inside China's top-tier engineering universities — Tsinghua, Zhejiang, and Shanghai Jiao Tong — where Li and the investment team track research labs and spin-out activity. Panda also draws referrals from its co-investor network, having syndicated deals alongside Sequoia Capital China and Tencent, which tends to surface startups before they formally run institutional rounds.

Panda is a private venture capital firm, but its AI and deep-tech focus naturally overlaps with Beijing's priority sectors. This alignment is not an ownership relationship — the firm does not report government LP capital in any public disclosure — but it creates structural access: portfolio companies may be eligible for state pilot programs or regulatory sandboxes that purely consumer-focused startups cannot reach.

Panda focuses on Seed, Start-up, and Early Stage rounds, occasionally participating in Series B extensions. Checks typically range from $1 million to $5 million in local-currency equivalents, positioning the firm as a lead or active co-lead in first institutional rounds for AI, fintech, and enterprise-software companies.

No philanthropic foundation, endowment, or non-profit vehicle is publicly associated with Panda Capital or its principals. The firm appears to operate as a pure for-profit venture capital manager without a parallel impact or charitable structure.

Panda Capital concentrates on enterprise-facing technology and avoids consumer internet plays — a deliberate counter-positioning during the era when consumer platforms dominated China's venture returns. The firm has not invested in gaming, e-commerce marketplaces, or social-media companies, and its healthcare exposure is limited to tech-enabled services and AI-driven drug discovery rather than traditional biotech or medical devices.

Panda Capital is an independent partnership, not a captive corporate venture unit. Unlike Baidu Ventures or Tencent Investment, Panda does not invest off a parent balance sheet or serve a corporate strategic mandate. Its co-investments with corporate strategic investors are arm's-length syndicate decisions, not dictated by a corporate parent's product roadmap.